"Calcitriol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.
| Descriptor ID |
D002117
|
| MeSH Number(s) |
D04.210.500.247.222.159.478.387.300 D04.210.500.247.808.146.478.387.300 D04.210.500.812.768.196.478.387.300 D10.570.938.146.478.387.300
|
| Concept/Terms |
Calcitriol- Calcitriol
- 1 alpha,25-Dihydroxyvitamin D3
- 1 alpha,25 Dihydroxyvitamin D3
- D3, 1 alpha,25-Dihydroxyvitamin
- alpha,25-Dihydroxyvitamin D3, 1
- 1,25-Dihydroxyvitamin D3
- 1,25 Dihydroxyvitamin D3
- D3, 1,25-Dihydroxyvitamin
- 1 alpha,25-Dihydroxycholecalciferol
- 1 alpha,25 Dihydroxycholecalciferol
- 1,25-Dihydroxycholecalciferol
- 1,25 Dihydroxycholecalciferol
20-epi-1alpha,25-dihydroxycholecaliferol- 20-epi-1alpha,25-dihydroxycholecaliferol
- 20 epi 1alpha,25 dihydroxycholecaliferol
- 1,25-dihydroxy-20-epi-Vitamin D3
- 1,25 dihydroxy 20 epi Vitamin D3
- D3, 1,25-dihydroxy-20-epi-Vitamin
- 1,25(OH)2-20epi-D3
- 1 alpha, 25-dihydroxy-20-epi-Vitamin D3
- 1 alpha, 25 dihydroxy 20 epi Vitamin D3
|
Below are MeSH descriptors whose meaning is more general than "Calcitriol".
Below are MeSH descriptors whose meaning is more specific than "Calcitriol".
This graph shows the total number of publications written about "Calcitriol" by people in this website by year, and whether "Calcitriol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Calcitriol" by people in Profiles.
-
Parenteral iron therapy and phosphorus homeostasis: A review. Am J Hematol. 2021 05 01; 96(5):606-616.
-
Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients. J Ren Nutr. 2016 07; 26(4):265-9.
-
Vitamin D and Cardiac Differentiation. Vitam Horm. 2016; 100:299-320.
-
1,25(OH)(2)vitamin D(3) enhances myogenic differentiation by modulating the expression of key angiogenic growth factors and angiogenic inhibitors in C(2)C(12) skeletal muscle cells. J Steroid Biochem Mol Biol. 2013 Jan; 133:1-11.
-
1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology. 2011 Aug; 152(8):2976-86.
-
Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl. 2010 Aug; (117):S10-21.
-
1,25(OH)2vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. J Steroid Biochem Mol Biol. 2010 Mar; 119(1-2):73-83.
-
Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med. 2008 Feb 25; 168(4):397-403.
-
Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Endocr Pract. 2008 Jan-Feb; 14(1):18-27.
-
Survival differences between activated injectable vitamin D2 and D3 analogs. Kidney Int. 2007 Apr; 71(8):827; author reply 827-8.